Silvio Danese
Silvio Danese
Unknown affiliation
No verified email
TitleCited byYear
The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management
A Dignass, G Van Assche, JO Lindsay, M Lémann, J Söderholm, ...
Journal of Crohn's and Colitis 4 (1), 28-62, 2010
2185*2010
Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice
A Swidsinski, V Loening-Baucke, H Lochs, LP Hale
World journal of gastroenterology: WJG 11 (8), 1131, 2005
1573*2005
Vedolizumab as induction and maintenance therapy for ulcerative colitis
BG Feagan, P Rutgeerts, BE Sands, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 699-710, 2013
12282013
Epithelial NEMO links innate immunity to chronic intestinal inflammation
A Nenci, C Becker, A Wullaert, R Gareus, G Van Loo, S Danese, M Huth, ...
Nature 446 (7135), 557, 2007
9142007
Extraintestinal manifestations in inflammatory bowel disease
S Danese, S Semeraro, A Papa, I Roberto, F Scaldaferri, G Fedeli, ...
World journal of gastroenterology 11 (46), 7227, 2005
744*2005
Tolerogenic dendritic cells: cytokine modulation comes of age
S Rutella, S Danese, G Leone
Blood 108 (5), 1435-1440, 2006
5492006
Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target
L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ...
The American journal of gastroenterology 110 (9), 1324, 2015
5482015
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis
R Panaccione, S Ghosh, S Middleton, JR Márquez, BB Scott, L Flint, ...
Gastroenterology 146 (2), 392-400. e3, 2014
5322014
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines
J Panes, Y Bouhnik, W Reinisch, J Stoker, SA Taylor, DC Baumgart, ...
Journal of Crohn's and Colitis 7 (7), 556-585, 2013
4552013
Development of the Crohn's disease digestive damage score, the Lemann score
B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ...
Inflammatory bowel diseases 17 (6), 1415-1422, 2010
4452010
Inflammatory bowel disease: the role of environmental factors
S Danese, M Sans, C Fiocchi
Autoimmunity reviews 3 (5), 394-400, 2004
4132004
Wound healing of intestinal epithelial cells
M Iizuka, S Konno
World journal of gastroenterology: WJG 17 (17), 2161, 2011
411*2011
Regulation of leukocyte recruitment by the long pentraxin PTX3
L Deban, RC Russo, M Sironi, F Moalli, M Scanziani, V Zambelli, ...
Nature immunology 11 (4), 328, 2010
3502010
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo …
A Tursi, G Brandimarte, A Papa, A Giglio, W Elisei, GM Giorgetti, G Forti, ...
The American journal of gastroenterology 105 (10), 2218, 2010
3492010
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis
S Danese, M Sans, C De La Motte, C Graziani, G West, MH Phillips, ...
Gastroenterology 130 (7), 2060-2073, 2006
3492006
Inflammation and coagulation in inflammatory bowel disease: the clot thickens
S Danese, A Papa, S Saibeni, A Repici, A Malesci, M Vecchi
The American journal of gastroenterology 102 (1), 174, 2007
3292007
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
RM Gadaleta, KJ Van Erpecum, B Oldenburg, ECL Willemsen, W Renooij, ...
Gut 60 (4), 463-472, 2011
3182011
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates
F Canducci, A Armuzzi, F Cremonini, G Cammarota, F Bartolozzi, P Pola, ...
Alimentary pharmacology & therapeutics 14 (12), 1625-1629, 2000
3032000
Tofacitinib as induction and maintenance therapy for ulcerative colitis
WJ Sandborn, C Su, BE Sands, GR D’Haens, S Vermeire, S Schreiber, ...
New England Journal of Medicine 376 (18), 1723-1736, 2017
2872017
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
J Panés, D García-Olmo, G Van Assche, JF Colombel, W Reinisch, ...
The Lancet 388 (10051), 1281-1290, 2016
2842016
The system can't perform the operation now. Try again later.
Articles 1–20